# New Imaging Biomarkers for Muscular Diseases - Multispectral Optoacoustic Imaging in Spinal Muscular Atrophy

> **NCT04115475** · NA · COMPLETED · sponsor: **University of Erlangen-Nürnberg Medical School** · enrollment: 20 (actual)

## Conditions studied

- Muscular Diseases
- Spinal Muscular Atrophy

## Interventions

- **DEVICE:** Multispectral Optoacoustic Tomography (MSOT)

## Key facts

- **NCT ID:** NCT04115475
- **Lead sponsor:** University of Erlangen-Nürnberg Medical School
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-11-07
- **Primary completion:** 2020-01-30
- **Final completion:** 2020-01-30
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2020-11-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04115475

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04115475, "New Imaging Biomarkers for Muscular Diseases - Multispectral Optoacoustic Imaging in Spinal Muscular Atrophy". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04115475. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*